Home › Compare › CGUD vs MRK

CGUD vs MRK: Dividend Comparison 2026

CGUD yields 250000.00% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CGUD wins by $4.567699004441311e+30M in total portfolio value
10 years
CGUD
CGUD
● Live price
250000.00%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$4.567699004441311e+30M
Annual income
$4,564,107,688,187,857,300,000,000,000,000,000,000.00
Full CGUD calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — CGUD vs MRK

📍 CGUD pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCGUDMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CGUD + MRK cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
CGUD pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CGUD
Annual income on $10K today (after 15% tax)
$21,250,000.00/yr
After 10yr DRIP, annual income (after tax)
$3,879,491,534,959,678,500,000,000,000,000,000,000.00/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, CGUD beats the other by $3,879,491,534,959,678,500,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CGUD + MRK for your $10,000?

CGUD: 50%MRK: 50%
100% MRK50/50100% CGUD
Portfolio after 10yr
$2.2838495022206556e+30M
Annual income
$2,282,053,844,093,928,700,000,000,000,000,000,000.00/yr
Blended yield
99.92%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

CGUD
No analyst data
Altman Z
-121.0
Piotroski
1/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CGUD buys
0
MRK buys
0
No recent congressional trades found for CGUD or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCGUDMRK
Forward yield250000.00% ✓2.76%
Annual dividend / share$2.00$3.32 ✓
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7% ✓
Portfolio after 10y$4.567699004441311e+30M$56.8K ✓
Annual income after 10y$4,564,107,688,187,857,300,000,000,000,000,000,000.00 ✓$9,798.13
Total dividends collected$4.567463897060879e+30M$28.9K ✓
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: CGUD vs MRK ($10,000, DRIP)

YearCGUD PortfolioCGUD Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$25,010,700$25,000,000.00$11,206$366.19+$25.00M → CGUD
2$58,462,976,402$58,436,214,953.27$12,650$502.35+$58462.96M → CGUD
3$127,722,124,784,416$127,659,569,399,665.92$14,407$694.19+$127722124.77M → CGUD
4$260,784,910,907,288,130$260,648,248,233,768,800.00$16,585$967.82+$260784910907.27M → CGUD
5$497,657,939,618,196,950,000$497,378,899,763,526,240,000.00$19,342$1,363.89+$497657939618196.94M → CGUD
6$887,590,576,640,622,200,000,000$887,058,082,645,230,600,000,000.00$22,913$1,947.19+$887590576640622208.00M → CGUD
7$1,479,547,418,610,237,200,000,000,000$1,478,597,696,693,231,600,000,000,000.00$27,662$2,823.89+$1.4795474186102372e+21M → CGUD
8$2,305,052,548,351,757,200,000,000,000,000$2,303,469,432,613,844,500,000,000,000,000.00$34,159$4,173.35+$2.3050525483517572e+24M → CGUD
9$3,356,370,330,330,650,300,000,000,000,000,000$3,353,903,924,103,914,000,000,000,000,000,000.00$43,337$6,308.80+$3.3563703303306504e+27M → CGUD
10$4,567,699,004,441,311,000,000,000,000,000,000,000$4,564,107,688,187,857,300,000,000,000,000,000,000.00$56,776$9,798.13+$4.567699004441311e+30M → CGUD

CGUD vs MRK: Complete Analysis 2026

CGUD — Stock

Com-Guard.com, Inc. provides software products for security and tracker applications. The company offers ComputerSafe, which detects, protects, and reports various computer system security threats, including identity theft and firewall break-ins, as well as recovers lost or stolen computers. It also licensed Missed Call Tracker software for loyalty programs for tracking member activities and payments. In addition, the company holds licenses for the Cash Engine Software. It has distribution and licensing agreements for North America, including Canada, Mexico, and the Caribbean with The Company USA PTY, Ltd. The company was formerly known as e-World Security, Inc. and changed its name to Com-Guard.com, Inc. in April 1999. Com-Guard.com, Inc. was incorporated in 1998 and is based in Encinitas, California.

Full CGUD Calculator →

MRK — Healthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this CGUD vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CGUD vs SCHDCGUD vs JEPICGUD vs OCGUD vs KOCGUD vs MAINCGUD vs JNJCGUD vs ABBVCGUD vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.